Endothelins and their receptors in cancer: identification of therapeutic targets

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Endothelins and their receptors play roles in normal physiology.
• Dysregulation of the endothelin axis is observed in various human cancers.
• This axis influences critical signaling pathways involved in cancer progression.

Purpose of the Study:

• To explore the role of the endothelin axis in cancer.
• To evaluate the potential of targeting the endothelin axis for novel anticancer therapies.
• To review current research on combining endothelin-axis-targeting drugs with established chemotherapeutics.

Main Methods:

• Review of existing literature on the endothelin axis in cancer.
• Analysis of signaling pathways affected by the endothelin axis (e.g., Ras, mTOR, NFκB).
• Investigation of selective endothelin receptor antagonists and agonists, and knockdown strategies.

Main Results:

• The endothelin axis is implicated in numerous cancer types.
• Combination therapies involving endothelin axis modulators show promising results.
• Understanding drug specificity and minimizing off-target effects are key challenges.

Conclusions:

• The endothelin axis represents a promising target for developing novel anticancer strategies.
• Further research is required to optimize drug specificity and clinical application.
• Targeting the endothelin axis holds potential for treating various cancers and other diseases.